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A B S T R A C T
Based on randomized controlled studies, cardiac resynchronization therapy (CRT) is 
currently indicated in patients with systolic heart failure of New York Heart Associa-
tion (NYHA) functional class III and IV, left ventricular ejection fraction <35% and 
wide QRS (>120 ms). Most of the enrolled patients were in sinus rhythm, were not 
previously paced and had mainly LBBB. Thus, there are uncertainties regarding sev-
eral other populations, not included or underrepresented in the main studies. These 
populations include patients with atrial fibrillation (AF), previous pacemakers con-
sidered for upgrade to CRT, RBBB, narrow QRS <120 ms, NYHA functional class 
<III, or right heart failure. These non-classical indications are herein reviewed.
Although CRT seems to benefit patients with AF and patients with preexisting pace-
makers, in patients with NYHA functional class II-III, or with narrow QRS, or with 
RBBB, or in those with predominant right heart failure, the role of CRT is not estab-
lished yet and further relevant clinical trials are needed.
I N T R O D U C T I O N
Cardiac resynchronization therapy (CRT) is currently indicated in patients with 
systolic heart failure of New York Heart Association (NYHA) functional class III 
and IV, left ventricular ejection fraction (EF) <35% and wide QRS (>120 ms).1 These 
indications are based on randomized controlled trials in which patients with these 
indications have been enrolled. Most of the patients enrolled into these studies were 
in sinus rhythm, were not previously paced and had left bundle branch block (LBBB) 
or another left intraventricular conduction delay.2-5
There are still uncertainties regarding several other populations that were not 
included or underrepresented in the main studies. These populations include patients 
with atrial fibrillation, patients with previous pacemakers who are being considered 
for upgrade to CRT, patients with right bundle branch block (RBBB), patients with 
narrow QRS <120 ms, patients with NYHA functional class lower than III, patients 
with low EF who need pacemakers for other indications and do not have wide QRS 
yet, and patients with predominantly right heart failure. We will review here our 
experience and the available literature to try to determine the benefits of CRT in 
these populations.
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AbbreviAtions
AF= atrial fibrillation
AV = atrioventricular
CHF= congestive heart failure
CRT = cardiac resynchronization therapy
CRT-D= cardiac resynchronization 
therapy-defibrillation
EF= (left ventricular) ejection fraction
LBBB= left bundle branch block
NYHA= New York Heart Association
RBBB = right bundle branch block
RV = right ventric-le(-ular)
TDI= tissue Doppler imaging
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PA T I e N T S  w I T h  C h R O N I C  A T R I A l 
f I B R I l l A T I O N
Patients with permanent atrial fibrillation (AF) were not 
included in most of the major studies, and therefore some 
guidelines that were recently published do not include them 
in the indications for CRT.6 However, there are several studies 
that looked specifically at this population and demonstrated 
the benefits of CRT. Most of them demonstrated similar or 
somewhat decreased but significant benefit in AF patients 
when compared to patients paced in sinus rhythm.7-13 It has 
been our experience as well that patients with atrial fibrillation 
improve with CRT as long as consistent pacing in the ventricles 
is achieved with appropriate rate control or atrioventricular 
(AV) nodal ablation. We have seen and are also aware of 
several reports of conversion of long-standing AF to sinus 
following establishment of CRT, which raises the possibility 
that an atrial lead may have to be placed in many patients with 
AF receiving CRT systems in anticipation of possible return 
to sinus rhythm. We therefore believe that CRT is indicated in 
patients with AF who otherwise have a CRT indication
PA T I e N T S  w I T h  P R e v I O U S  PA C e m A K e R S
Patients with prior pacemakers with systolic heart failure 
were not included in the major CRT trials, but all series that 
looked specifically into this population demonstrated benefit 
that was similar or even greater than the benefit in the tradi-
tional CRT population.10,11,14 We have also shown in 25 patients 
with prior pacing a somewhat better response to CRT than in 
patients with de novo CRT implantation.15 Selection criteria 
for CRT among pacemaker patients are not established yet, but 
it is conceivable that paced QRS width is not an appropriate 
selection criterion, and measures of mechanical dyssynchrony 
may have to be taken into account.16
PA T I e N T S  w I T h  R B B B
Although patients with RBBB were included in several 
major trials,4,5,17 their results were not analyzed separately until 
recently, and they were not excluded from present indications 
in the current guidelines.1,6 Nevertheless, a recent publication 
based on more than 60 cases demonstrated very little benefit of 
CRT in RBBB patients.17 Garrigue et al18 have demonstrated in 
the past a beneficial effect of CRT in patients with RBBB, but 
only in those having measures of mechanical dyssynchrony. It 
is conceivable that RBBB serves as a marker of left ventricular 
dyssynchrony in many but not all of CRT candidates, and it 
is therefore reasonable to decide on CRT implantation in 
patients with RBBB based on measures of mechanical dys-
synchrony such as tissue Doppler imaging (TDI).
PA T I e N T S  w I T h  N A R R O w  Q R S
Information is scarce about CRT in this population. As 
research in this area is expanding, it is becoming clearer that 
the traditional selection criteria of wide QRS are limited in 
their ability to predict success of CRT and that they are only 
markers of mechanical dyssynchrony, measures of which may 
provide better prediction of success.19 It has been shown that 
there are quite a few patients with congestive heart failure 
(CHF) and narrow QRS (≤120 ms) who have intraventricular 
dyssynchrony, and it has been shown in limited numbers of 
patients that CRT may benefit patients with narrow QRS 
if they have mechanical dyssynchrony.20,21 This topic is the 
subject of intensive research in ongoing randomized control-
led studies.
PA T I e N T S  w I T h O U T  O v e R T  h e A R T  fA I l U R e
Some of the major CRT-D trials included patients with 
NYHA class II heart failure.22,23 These studies demonstrated 
an effect on echocardiographic measures of cardiac remod-
eling but very limited clinical effect on heart failure symptoms 
in this group. At this point, evidence is insufficient to recom-
mend CRT in functional class class I or II patients. Ongoing 
randomized controlled trials are looking into this matter.
PA T I e N T S  w I T h  C h f  w h O  N e e D  PA C e m A K e R 
I m P l A N T A T I O N
We often face patients with heart failure who need pace-
maker implantation for bradycardic indication but do not 
have wide QRS yet. However, when paced they are likely to 
develop dyssynchrony and may deteriorate further, therefore 
the question of a priori CRT implantation is raised.
This issue was recently addressed by the PAVE trial which 
demonstrated beneficial effect to a priori CRT vs traditional 
pacing in patients undergoing AV nodal ablation especially 
in patients with EF <45% and with CHF symptoms (NYHA 
II-III).24 Whether this approach will apply to other patient 
populations undergoing pacemaker implantation will depend 
on the results of ongoing trials.
PA T I e N T S  w I T h  R I g h T  h e A R T  fA I l U R e
This population is mixed within the populations of the 
large trials, and very few studies looked specifically at these 
patients as candidates for CRT. A small series of congenital 
heart disease patients demonstrated the benefit of CRT, but 
this population is unlike the usual CRT candidate.25 We have 
shown a beneficial effect of CRT on myocardial performance 
index of the right ventricle.26 We also demonstrated the ben-
eficial effect of CRT on functional capacity of seven patients 
with combined left and right heart failure.27 Recently we have 
been able to show that among 20 patients with reduced right 
ventricular (RV) function (as expressed by RV fractional area 
shortening), 65% improved their RV function after three 
months of CRT. This improvement was correlated with the 
degree of improvement in NYHA functional class (unpub-
lished data).
NON-CLASSICAL INDICATIONS FOR CRT
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C O N C l U S I O N S
Whereas the role of CRT is established in patients with 
the classical indications, its role is not established in several 
populations that are reviewed in this overview. Although CRT 
seems to benefit patients with AF and patients with preexisting 
pacemakers, its role in patients with NYHA functional class 
I – II, in patients with narrow QRS, in patients with RBBB, 
in patients who need pacing for other indications who do not 
have wide QRS and in patients with predominant right heart 
failure is not established yet. Many of these questions may 
be solved in the future by use of better predictors of success 
such as echo TDI, and will eventually be answered by ongoing 
clinical trials.
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